Old Web
English
Sign In
Acemap
>
authorDetail
>
Pauline Hulo
Pauline Hulo
French Institute of Health and Medical Research
Immunology
Medicine
Mutation
Oncogene Addiction
first line therapy
1
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EGFR mutation-positive NSCLC: factors to consider when deciding first-line therapy.
2020
Expert Review of Anticancer Therapy
Pauline Hulo
Dahna Coupez
M. G. Denis
Jaafar Bennouna
Show All
Source
Cite
Save
Citations (4)
1